IEyeNews

iLocal News Archives

Cayman: Public Health Spotlight – Issue 5 – Epi Week 25

From Cayman Islands Public Health Department

COVID-19 – Epidemiological Week 25 
19 – 25 June 2022 (Data as of 27-06-2022)

International Situation 
Globally, there has been a decline in COVID-19 cases and deaths reported in the previous week. Omicron continues to be the predominant variant circulating internationally, specifically in the BA.2 lineage and BA.5 lineage. 

Cayman Islands Local Trends
In the Cayman Islands, an increase has been reported in key indicators over the past week, with an increase of 15% in the case rate from 532 cases per 100,000 population to 611 cases per 100,000. The number of newly confirmed cases has increased to 424 in Epi Week 25 from 369. The number of testing conducted in the past week has remained relatively stable and test positivity has increased slightly to 28% from 26% in the previous week. One new death has been reported in Epi Week 25, bringing the total number of COVID-19 deaths to 29.

Hospital Admissions
 Ten new admissions were registered during Epi. Week 25, an increase from the previous reporting week where five new admissions were reported. Of the ten admissions, six were admitted due to COVID-19 morbidity, and four were patients were detected on screening. A total of 12 patients required inpatient treatment, which increased from 9 patients in the previous week. 


Vaccination

During Epi. Week 25, there were 134 adults who received a COVID-19 vaccine (48 first dose and 86 second dose) and 66 children (22 first dosed and 44 second dose). Among those over 20 years of age, vaccine coverage of the booster (third dose) is 42.8%, and among those over 70 years the booster coverage is 68.7%.

Key Message 

Epidemiological metrics have fluctuated the past few weeks and ongoing transmission appears to be plateauing rather than declining after the recent wave of infections.

Web version can be found here: https://www.gov.ky/news/press-release-details/public-health-spotlight—issue-5

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *